hi guys
Did you see what happened with insider trading on clinical results (http://dealbook.nytimes.com/2014/01/15/doctor-at-insider-trading-trial-testifies-it-was-like-he-was-in-the-room/)
if the results are not released to the market there would be much opportunity for insider trading. In fact for most studies the blood tests will be done by on independent 3 rd party, and I believe this is the case for Invion's Lupus Ph 2.
So when the prelim results come in to the Board from the independent 3rd party, i'm having trouble understanding how under the rules they could not announce... how could they tell another pharma company and not tell us investors?
re CR this also means i think it will go
1. announce results
2. CR
or they could just go CR, which would probably mean a bit of a dip (i would not be happy!) :)
agree?
- Forums
- ASX - By Stock
- IVX
- financial position and lupus study inv103
financial position and lupus study inv103, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $13.53M |
Open | High | Low | Value | Volume |
0.2¢ | 0.3¢ | 0.2¢ | $8.414K | 4.069M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
51 | 51070126 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 8800521 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
51 | 51123256 | 0.002 |
24 | 29757193 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 8800521 | 24 |
0.004 | 14436124 | 15 |
0.005 | 6343282 | 21 |
0.006 | 738326 | 3 |
0.007 | 1867119 | 4 |
Last trade - 15.27pm 17/10/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online